Status:
COMPLETED
Efficiency of Autologous Amniotic Fluid Injection in the Healing of Cesarean Section Scar in High-Risk Population
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
High Risk Pregnancy
Healing Surgical Wounds
Eligibility:
FEMALE
30-45 years
Phase:
PHASE4
Brief Summary
The goal of this randomized controlled trial is to investigate the effect of injection of autologous amniotic fluid in the healing of the scar of cesarean section among high-risk population. Investiga...
Detailed Description
After surgery, participants will be observed along 6 weeks (at 1, 2 and 6 weeks intervals) and scars will be assessed regarding color, thickness, pliability and presence of exudate.
Eligibility Criteria
Inclusion
- Age \> 30 years old.
- Anemic patients
- Maternal chronic disease e.g., Diabetes and Hypertension
- BMI of \> 25 Kg/m2.
- Underwent previous CS.
Exclusion
- Rupture of membrane.
- No previous section.
- Anhydraminos.
- Congenital malformation of the fetus.
Key Trial Info
Start Date :
February 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 20 2024
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT06531356
Start Date
February 16 2024
End Date
May 20 2024
Last Update
August 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
kasr Al Aini, Faculty of Medicine, Cairo University
Cairo, Old Cairo, Egypt, 11562